Sign In
Buy DGX
$233.72
+1.77 (+0.763%)
At Close: Aug 04, 2026
Thermo Fisher (TMO) Q2 Earnings Top Estimates, Margins Down
02:44pm, Thursday, 28'th Jul 2022 Zacks Investment Research
The year-over-year decline in Thermo Fisher's (TMO) Life Science Solutions and Specialty Diagnostics segment revenues is disappointing.
West Pharmaceutical (WST) Q2 Earnings Beat, FY22 View Cut
01:53pm, Thursday, 28'th Jul 2022 Zacks Investment Research
West Pharmaceutical's (WST) second-quarter earnings reflect strength in the Proprietary Products segment.
Merit Medical (MMSI) Q2 Earnings Beat, FY22 View Revised
01:51pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Merit Medical (MMSI), in the second quarter, benefits from revenue growth in both its segments and from all product categories within its Cardiovascular unit.
3 MedTech Stocks That are Likely to Beat This Earnings Season
12:23pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how STE, TMO and IDXX are poised ahead of their earnings releases.
4 Analysts Have This to Say About Quest Diagnostics
06:38pm, Friday, 22'nd Jul 2022 Benzinga
Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
0
3
0
0
Tenet Healthcare (THC) Q2 Earnings Beat, Trims '22 EPS View
03:51pm, Friday, 22'nd Jul 2022 Zacks Investment Research
Tenet Healthcare's (THC) second-quarter earnings benefit from strong Ambulatory Care and Conifer segments. However, a trimmed EPS view for 2022 might raise concerns for investors.
Quest Diagnostics Incorporated (DGX) CEO Steve Rusckowski on Q2 2022 Results - Earnings Call Transcript
04:14pm, Thursday, 21'st Jul 2022
Quest Diagnostics Incorporated (NYSE:DGX ) Q2 2022 Earnings Conference Call July 21, 2022 8:30 AM ET Company Participants Shawn Bevec - Vice President of Investor Relations Steve Rusckowski - Chairman
Quest Diagnostics (DGX) Tops Q2 Earnings Estimates, Ups View
02:03pm, Thursday, 21'st Jul 2022 Zacks Investment Research
Banking on consistent improvement in the company's Base business, Quest Diagnostics (DGX) raises its full-year 2022 guidance.
Quest Diagnostics (DGX) Tops Q2 Earnings and Revenue Estimates
12:05pm, Thursday, 21'st Jul 2022 Zacks Investment Research
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 4.42% and 4.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Quest Diagnostics (DGX) Tops Q2 Earnings Estimates, Ups View
11:39am, Thursday, 21'st Jul 2022
Banking on consistent improvement in the company's Base business, Quest Diagnostics (DGX) raises its full-year 2022 guidance.
Quest Diagnostics (DGX) Tops Q2 Earnings and Revenue Estimates
10:07am, Thursday, 21'st Jul 2022
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 4.42% and 4.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Quest Diagnostics profit drops but testing firm raises 2022 view
07:03am, Thursday, 21'st Jul 2022
Quest Diagnostics Inc. DGX, -1.33% said Thursday its second-quarter net income fell to $234 million, or $1.96 a share from $631 million, or $4.96 a share in the year-ago quarter. Adjusted profit in th
5 Dividend-Paying Stocks to Buy Ahead of Earnings Next Week
09:54am, Friday, 15'th Jul 2022 Zacks Investment Research
Five dividend-paying companies will report second-quarter 2022 earnings results next week. These are: HAL, FNB, DGX, SLB and NEP.
5 Dividend-Paying Stocks to Buy Ahead of Earnings Next Week
08:19am, Friday, 15'th Jul 2022
Five dividend-paying companies will report second-quarter 2022 earnings results next week. These are: HAL, FNB, DGX, SLB and NEP.
Quest Diagnostics (DGX) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
02:00pm, Thursday, 14'th Jul 2022 Zacks Investment Research
Quest Diagnostics (DGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
